| Code | 3059E | ||||||||||
| MA number | 18/0038/23-S | ||||||||||
| Product Form: | tbl flm 10x50 mg/1000 mg (blis.OPA/Al/PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TAD Pharma GmbH, Germany | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 17.02.2023 |
| Validity: | 17.02.2028 |
| SPC: |
SPC_Asigefort filmom obalené tablety_03.2025.pdf
|
| PIL: |
PIL_Asigefort filmom obalené tablety_03.2025.pdf
|
| Safety feature | Yes |
| Data update: | 17.02.2023 |
